At a hearing yesterday, Senate HELP leadership said they would likely include supply chain safety measures in the major drug user fee re-authorization next year (PDUFA V), and showed bipartisan interest in how FDA is dealing with the challenges posed by a

Industry user fees are one of the few ways to raise revenue it seems we haven’t heard much about over the past few weeks, as Congress has become engulfed in the debt ceiling debate. But they're nevertheless a critical piece in funding the FDA’s system to

Women could start seeing some big advancements in preventive care services as part of the Affordable Care Act if the recommendations from Tuesday’s Institute of Medicine (IOM) report, Clinical Preventive Services for Women: Closing the Gaps, are accepted

Late last summer, the Association of American Medical Colleges attempted at the eleventh hour to significantly weaken proposed rules to tighten up conflict of interest policies for NIH-funded biomedical research. Now the rule, which would require institut

An OIG report issued Monday found that only a few state Medicaid programs have made plans to replace a widely-used but fraud-ridden pricing system for pharmacy reimbursement that will be discontinued this coming September in response to a consumer lawsui

The current political debate in Washington suffers from a narrowing of the political space that is considered “serious.” The problem extends well beyond the relative importance and urgency of reducing the national debt and addressing the persistently high

Last week, Maine's governor signed LD719 into law, repealing a series of pharma transparency laws including one that required drug companies to report certain marketing costs, including meals and gifts to physicians. I talked with Maine representative and

Providing insurance to low-income populations, as Medicaid does, improves their overall health and helps maintain financial stability. A new study by the National Bureau of Economic Research, says that Medicaid recipients, on average, were more likely to

Consumer advocates have a new opportunity to influence regional work to strengthen health equity. This is your chance to make a difference! The Office of Minority Health in the federal Department of Health and Human Services is seeking nominations for 10